Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems

Journal of Controlled Release

Volumn 229, Issue , 2016, Pages 130-139

  Zhang, Dongdong ^a,b   Wang, Jiaxi ^a   Xu, Donggang ^a,b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cell penetrating peptides; Drug delivery system; Macromolecule transportation; Noninvasive transmembrane

Indexed keywords

BIOCHEMISTRY; BLOOD; CARDIOVASCULAR SYSTEM; CYTOLOGY; MACROMOLECULES; MOLECULAR BIOLOGY; PEPTIDES;

CELL PENETRATING PEPTIDES (CPPS); CELL-PENETRATING PEPTIDE; CELLULAR INTERNALIZATION; CENTRAL NERVOUS SYSTEMS; DRUG DELIVERY SYSTEM; HYDROPHILIC MACROMOLECULES; PERCUTANEOUS DELIVERIES; TRANSMEMBRANES;

CELLS;

AMINO ACID; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; CAMPTOTHECIN; CELL PENETRATING PEPTIDE; DOXORUBICIN; GLYCOSAMINOGLYCAN; IMMUNOLIPOSOME; INSULIN; LIPOSOME; METAL NANOPARTICLE; NATURAL PROTEIN DERIVED CELL PENETRATING PEPTIDE; PENETRATIN; PHOSPHOLIPID; POLYMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CHIMERA; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; GASTROINTESTINAL MUCOSA; HUMAN; NONHUMAN; PEPTIDE LIBRARY; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SKIN PENETRATION; SUSTAINED DRUG RELEASE; TUMOR MICROENVIRONMENT; ANIMAL; CELL MEMBRANE; METABOLISM;

ANIMALS; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS;

EID: 84962420971     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.03.020     Document Type: Review

References (105)

1. S.M. Farkhani, A. Valizadeh, H. Karami, S. Mohammadi, N. Sohrabi, and F. Badrzadeh Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules Peptides 57 2014 78 94
2. W.B. Kauffman, T. Fuselier, J. He, and W.C. Wimley Mechanism matters: a taxonomy of cell penetrating peptides Trends Biochem. Sci. 40 2015 749 764
3. J. Lin, and A. Alexander-Katz Cell membranes open "doors" for cationic nanoparticles/biomolecules: insights into uptake kinetics ACS Nano 7 2013 10799 10808
4. I. Nakase, H. Akita, K. Kogure, A. Graslund, U. Langel, H. Harashima, and S. Futaki Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides Acc. Chem. Res. 45 2012 1132 1139
5. M. Gebbing, T. Bergmann, E. Schulz, and A. Ehrhardt Gene therapeutic approaches to inhibit hepatitis B virus replication World J. Hepatol. 7 2015 150 164
6. S. Trabulo, A.L. Cardoso, A.M. Cardoso, C.M. Morais, A.S. Jurado, and M.C. Pedroso de Lima Cell-penetrating peptides as nucleic acid delivery systems: from biophysics to biological applications Curr. Pharm. Des. 19 2013 2895 2923
7. M.J. Pina, S.M. Alex, F.J. Arias, M. Santos, J.C. Rodriguez-Cabello, R.M. Ramesan, and C.P. Sharma Elastin-like recombinamers with acquired functionalities for gene-delivery applications J. Biomed. Mater. Res. A 103 2015 3166 3178
8. J.M. Swiecicki, M. Di Pisa, F. Lippi, S. Chwetzoff, C. Mansuy, G. Trugnan, G. Chassaing, S. Lavielle, and F. Burlina Unsaturated acyl chains dramatically enhanced cellular uptake by direct translocation of a minimalist oligo-arginine lipopeptide Chem. Commun. (Camb) 51 2015 14656 14659
9. C. Douat, C. Aisenbrey, S. Antunes, M. Decossas, O. Lambert, B. Bechinger, A. Kichler, and G. Guichard A cell-penetrating foldamer with a bioreducible linkage for intracellular delivery of DNA Angew. Chem. Int. Ed. Eng. 54 2015 11133 11137
10. Q.Y. Zhang, H.L. Gao, and Q. He Taming cell penetrating peptides: never too old to teach old dogs new tricks Mol. Pharm. 12 2015 3105 3118
11. Y. Yang, Y.F. Yang, X.Y. Xie, X.S. Cai, and X.G. Mei Synergistic targeted delivery of payload into cancer cells using liposomes co-modified with photolabile-caged cell-penetrating peptides and targeting ligands J. Control. Release 213 2015 E128
12. M.D. Barbosa Immunogenicity of biotherapeutics in the context of developing biosimilars and biobetters Drug Discov. Today 16 2011 345 353
13. A. Patel, K. Cholkar, and A.K. Mitra Recent developments in protein and peptide parenteral delivery approaches Ther. Deliv. 5 2014 337 365
14. Y. Sun, and Y.-H. Hu Cell-penetrating peptide-mediated subunit vaccine generates a potent immune response and protection against streptococcus iniae in Japanese flounder (Paralichthys olivaceus) Vet. Immunol. Immunopathol. 167 2015 96 103
15. J.D. Ramsey, and N.H. Flynn Cell-penetrating peptides transport therapeutics into cells Pharmacol. Ther. 154 2015 78 86
16. E. Vives Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions J. Mol. Recognit. 16 2003 265 271
17. I. Nakase, H. Hirose, G. Tanaka, A. Tadokoro, S. Kobayashi, T. Takeuchi, and S. Futaki Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis Mol. Ther. 17 2009 1868 1876
18. J.G. Rodriguez Plaza, R. Morales-Nava, C. Diener, G. Schreiber, Z.D. Gonzalez, M.T. Lara Ortiz, I. Ortega Blake, O. Pantoja, R. Volkmer, E. Klipp, A. Herrmann, and G. Del Rio Cell penetrating peptides and cationic antibacterial peptides: two sides of the same coin J. Biol. Chem. 289 2014 14448 14457
19. K. Splith, and I. Neundorf Antimicrobial peptides with cell-penetrating peptide properties and vice versa Eur. Biophys. J. 40 2011 387 397
20. X. Yu, Z. Xu, J. Lei, T. Li, and Y. Wang VP22 mediates intercellular trafficking and enhances the in vitro antitumor activity of PTEN Mol. Med. Rep. 12 2015 1286 1290
21. K. Hew, S.L. Dahlroth, L.X. Pan, T. Cornvik, and P. Nordlund VP22 core domain from herpes simplex virus 1 reveals a surprising structural conservation in both the alpha- and gammaherpesvirinae subfamilies J. Gen. Virol. 96 2015 1436 1445
22. C. D'Souza, S.T. Henriques, C.K. Wang, and D.J. Craik Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1 Eur. J. Med. Chem. 88 2014 10 18
23. L. Cascales, S.T. Henriques, M.C. Kerr, Y.H. Huang, M.J. Sweet, N.L. Daly, and D.J. Craik Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides J. Biol. Chem. 286 2011 36932 36943
24. A. Fittipaldi, and M. Giacca Transcellular protein transduction using the Tat protein of HIV-1 Adv. Drug Deliv. Rev. 57 2005 597 608
25. A. Okada, A. Kodaira, S. Hanyu, S. Izume, K. Ohya, and H. Fukushi Intracellular localization of equine herpesvirus type 1 tegument protein VP22 Virus Res. 192 2014 103 113
26. D. Derossi, G. Chassaing, and A. Prochiantz Trojan peptides: the penetratin system for intracellular delivery Trends Cell Biol. 8 1998 84 87
27. S. Galdiero, A. Falanga, G. Morelli, and M. Galdiero gH625: a milestone in understanding the many roles of membranotropic peptides Biochim. Biophys. Acta 1848 2015 16 25
28. R. Tarallo, T.P. Carberry, A. Falanga, M. Vitiello, S. Galdiero, M. Galdiero, and M. Weck Dendrimers functionalized with membrane-interacting peptides for viral inhibition Int. J. Nanomedicine 8 2013 521 534
29. M.P. Schutze-Redelmeier, H. Gournier, F. Garcia-Pons, M. Moussa, A.H. Joliot, M. Volovitch, A. Prochiantz, and F.A. Lemonnier Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo J. Immunol 157 1996 1950 650 655
30. J. Ruczynski, P.M. Wierzbicki, M. Kogut-Wierzbicka, P. Mucha, K. Siedlecka-Kroplewska, and P. Rekowski Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells Folia Histochem. Cytobiol. 52 2014 257 269
31. N.Q. Shi, X.R. Qi, B. Xiang, and Y. Zhang A survey on "Trojan horse" peptides: opportunities, issues and controlled entry to "Troy" J. Control. Release 194 2014 53 70
32. M. Wojciechowska, J. Ruczynski, P. Rekowski, M. Alenowicz, P. Mucha, M. Pieszko, A. Miszka, M. Dobkowski, and H. Bluijssen Synthesis and hybridization studies of a new CPP-PNA conjugate as a potential therapeutic agent in atherosclerosis treatment Protein Pept. Lett. 21 2014 672 678
33. E.J. Sayers, K. Cleal, N.G. Eissa, P. Watson, and A.T. Jones Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides J. Control. Release 195 2014 55 62
34. F. Wang, Y. Wang, X. Zhang, W. Zhang, S. Guo, and F. Jin Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery J. Control. Release 174 2014 126 136
35. D.M. Copolovici, K. Langel, E. Eriste, and U. Langel Cell-penetrating peptides: design, synthesis, and applications ACS Nano 8 2014 1972 1994
36. S.R. MacEwan, and A. Chilkoti Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5 2013 31 48
37. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 2001 5836 5840
38. S. Futaki Membrane-permeable arginine-rich peptides and the translocation mechanisms Adv. Drug Deliv. Rev. 57 2005 547 558
39. H.L. Amand, K. Fant, B. Norden, and E.K. Esbjorner Stimulated endocytosis in penetratin uptake: effect of arginine and lysine Biochem. Biophys. Res. Commun. 371 2008 621 625
40. Y.H. Wang, C.P. Chen, M.H. Chan, M. Chang, Y.W. Hou, H.H. Chen, H.R. Hsu, K. Liu, and H.J. Lee Arginine-rich intracellular delivery peptides noncovalently transport protein into living cells Biochem. Biophys. Res. Commun. 346 2006 758 767
41. M. Chang, J.C. Chou, C.P. Chen, B.R. Liu, and H.J. Lee Noncovalent protein transduction in plant cells by macropinocytosis New Phytol. 174 2007 46 56
42. B.R. Liu, H.H. Chen, M.H. Chan, Y.W. Huang, R.S. Aronstam, and H.J. Lee Three arginine-rich cell-penetrating peptides facilitate cellular internalization of red-emitting quantum dots J. Nanosci. Nanotechnol. 15 2015 2067 2078
43. B.R. Liu, J.F. Li, S.W. Lu, H.J. Leel, Y.W. Huang, K.B. Shannon, and R.S. Aronstam Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides J. Nanosci. Nanotechnol. 10 2010 6534 6543
44. Y.J. Chen, B.R. Liu, Y.H. Dai, C.Y. Lee, M.H. Chan, H.H. Chen, H.J. Chiang, and H.J. Lee A gene delivery system for insect cells mediated by arginine-rich cell-penetrating peptides Gene 493 2012 201 210
45. S. Yamano, J. Dai, S. Hanatani, K. Haku, T. Yamanaka, M. Ishioka, T. Takayama, C. Yuvienco, S. Khapli, A.M. Moursi, and J.K. Montclare Long-term efficient gene delivery using polyethylenimine with modified Tat peptide Biomaterials 35 2014 1705 1715
46. B.X. Zhao, Y. Zhao, Y. Huang, L.M. Luo, P. Song, X. Wang, S. Chen, K.F. Yu, X. Zhang, and Q. Zhang The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel Biomaterials 33 2012 2508 2520
47. M.C. Morris, J. Depollier, J. Mery, F. Heitz, and G. Divita A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 19 2001 1173 1176
48. M.J. Kim, M. Park, D.W. Kim, M.J. Shin, O. Son, H.S. Jo, H.J. Yeo, S.B. Cho, J.H. Park, C.H. Lee, D.S. Kim, O.S. Kwon, J. Kim, K.H. Han, J. Park, W.S. Eum, and S.Y. Choi Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model Biomaterials 64 2015 45 56
49. Z. Ke, A. Gao, P. Xu, J. Wang, L. Ji, and J. Yang Preconditioning with PEP-1-SOD1 fusion protein attenuates ischemia/reperfusion-induced ventricular arrhythmia in isolated rat hearts Exp. Ther. Med. 10 2015 352 356
50. A. Chugh, and F. Eudes Cellular uptake of cell-penetrating peptides pVEC and transportan in plants J. Pept. Sci. 2008 477 481
51. J.B. Delehanty, C.E. Bradburne, K. Boeneman, K. Susumu, D. Farrell, B.C. Mei, J.B. Blanco-Canosa, G. Dawson, P.E. Dawson, H. Mattoussi, and I.L. Medintz Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system Integr. Biol. (Camb). 2 2010 265 277
52. K. Boeneman, J.B. Delehanty, J.B. Blanco-Canosa, K. Susumu, M.H. Stewart, E. Oh, A.L. Huston, G. Dawson, S. Ingale, R. Walters, M. Domowicz, J.R. Deschamps, W.R. Algar, S. Dimaggio, J. Manono, C.M. Spillmann, D. Thompson, T.L. Jennings, P.E. Dawson, and I.L. Medintz Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials ACS Nano 7 2013 3778 3796
53. Y. Chen, Y. Shen, X. Guo, C. Zhang, W. Yang, M. Ma, S. Liu, M. Zhang, and L.P. Wen Transdermal protein delivery by a coadministered peptide identified via phage display Nat. Biotechnol. 24 2006 455 460
54. M. Whitney, J.L. Crisp, E.S. Olson, T.A. Aguilera, L.A. Gross, L.G. Ellies, and R.Y. Tsien Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides J. Biol. Chem. 285 2010 22532 22541
55. K. Kamide, H. Nakakubo, S. Uno, and A. Fukamizu Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications Int. J. Mol. Med. 25 2010 41 51
56. E. Kondo, K. Saito, Y. Tashiro, K. Kamide, S. Uno, T. Furuya, M. Mashita, K. Nakajima, T. Tsumuraya, N. Kobayashi, M. Nishibori, M. Tanimoto, and M. Matsushita Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems Nat. Commun. 3 2012 951
57. E. Perillo, E. Allard-Vannier, A. Falanga, P. Stiuso, M.T. Vitiello, M. Galdiero, S. Galdiero, and I. Chourpa Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells Int. J. Pharm. 488 2015 59 66
58. S.K. Kim, M.B. Foote, and L. Huang The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles Biomaterials 33 2012 3959 3966
59. L.H. Peng, J. Niu, C.Z. Zhang, W. Yu, J.H. Wu, Y.H. Shan, X.R. Wang, Y.Q. Shen, Z.W. Mao, W.Q. Liang, and J.Q. Gao TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells Biomaterials 35 2014 5605 5618
60. T.I. Kim, J.U. Baek, J.K. Yoon, J.S. Choi, K. Kim, and J.S. Park Synthesis and characterization of a novel arginine-grafted dendritic block copolymer for gene delivery and study of its cellular uptake pathway leading to transfection Bioconjug. Chem. 18 2007 309 317
61. H. Kang, R. DeLong, M.H. Fisher, and R.L. Juliano Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides Pharm. Res. 22 2005 2099 2106
62. T. Kanazawa, K. Morisaki, S. Suzuki, and Y. Takashima Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles Mol. Pharm. 11 2014 1471 1478
63. H.P. Song, J.Y. Yang, S.L. Lo, Y. Wang, W.M. Fan, X.S. Tang, J.M. Xue, and S. Wang Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide Biomaterials 31 2010 769 778
64. L. Liu, J. Yang, J. Xie, Z. Luo, J. Jiang, Y.Y. Yang, and S. Liu The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes Nanoscale 5 2013 3834 3840
65. L. Pan, J. Liu, Q. He, L. Wang, and J. Shi Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles Biomaterials 34 2013 2719 2730
66. N. Jimenez-Mancilla, G. Ferro-Flores, C. Santos-Cuevas, B. Ocampo-Garcia, M. Luna-Gutierrez, E. Azorin-Vega, K. Isaac-Olive, M. Camacho-Lopez, and E. Torres-Garcia Multifunctional targeted therapy system based on (99 m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells J. Label. Compd. Radiopharm. 56 2013 663 671
67. T. Murakami, H. Nakatsuji, N. Morone, J.E. Heuser, F. Ishidate, M. Hashida, and H. Imahori Mesoscopic metal nanoparticles doubly functionalized with natural and engineered lipidic dispersants for therapeutics ACS Nano 8 2014 7370 7376
68. S. Liu, H. Yang, L. Wan, J. Cheng, and X. Lu Penetratin-mediated delivery enhances the antitumor activity of the cationic antimicrobial peptide Magainin II Cancer Biother. Radiopharm. 28 2013 289 297
69. H. Yang, S. Liu, H. Cai, L. Wan, S. Li, Y. Li, J. Cheng, and X. Lu Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria-disrupting peptides J. Biol. Chem. 285 2010 25666 25676
70. H. Young Kim, S. Young Yum, G. Jang, and D.R. Ahn Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier Sci. Report. 5 2015 11719
71. S.M. Sagnella, J.A. McCarroll, and M. Kavallaris Drug delivery: beyond active tumour targeting Nanomedicine 10 2014 1131 1137
72. Y. Kawasaki, and T. Akiyama Tumor microenvironment: promising therapeutic target Nihon Rinsho 73 2015 1283 1287
73. J. Conde, A. Ambrosone, V. Sanz, Y. Hernandez, V. Marchesano, F. Tian, H. Child, C.C. Berry, M.R. Ibarra, P.V. Baptista, C. Tortiglione, and J.M. de la Fuente Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing ACS Nano 6 2012 8316 8324
74. C.L. Santos-Cuevas, G. Ferro-Flores, C. Arteaga de Murphy, M. Ramirez Fde, M.A. Luna-Gutierrez, M. Pedraza-Lopez, R. Garcia-Becerra, and D. Ordaz-Rosado Design, preparation, in vitro and in vivo evaluation of (99 m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical Int. J. Pharm. 375 2009 75 83
75. M. Hyvonen, and P. Laakkonen Identification and characterization of homing peptides using in vivo peptide phage display Methods Mol. Biol. 1324 2015 205 222
76. Y. Liu, L. Mei, Q. Yu, Q. Zhang, H. Gao, Z. Zhang, and Q. He Integrin alphabeta targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides Amino Acids 47 2015 2533 2539
77. G. Sharma, A. Modgil, T. Zhong, C. Sun, and J. Singh Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier Pharm. Res. 31 2014 1194 1209
78. E. Koren, A. Apte, A. Jani, and V.P. Torchilin Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity J. Control. Release 160 2012 264 273
79. F. Araujo, N. Shrestha, M.A. Shahbazi, D. Liu, B. Herranz-Blanco, E.M. Makila, J.J. Salonen, J.T. Hirvonen, P.L. Granja, B. Sarmento, and H.A. Santos Microfluidic assembly of a multifunctional tailorable composite system designed for site specific combined oral delivery of peptide drugs ACS Nano 9 2015 8291 8302
80. D.K. Schach, W. Rock, J. Franz, M. Bonn, S.H. Parekh, and T. Weidner Reversible activation of a cell-penetrating peptide in a membrane environment J. Am. Chem. Soc. 137 2015 12199 12202
81. W. Li, F. Nicol, and F.C. Szoka Jr. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery Adv. Drug Deliv. Rev. 56 2004 967 985
82. J. Regberg, L. Vasconcelos, F. Madani, U. Langel, and M. Hallbrink pH-responsive PepFect cell-penetrating peptides Int. J. Pharm. 501 2016 32 38
83. Y. Yang, Y. Yang, X. Xie, X. Cai, H. Zhang, W. Gong, Z. Wang, and X. Mei PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy Biomaterials 35 2014 4368 4381
84. S.R. Macewan, and A. Chilkoti Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake Nano Lett. 12 2012 3322 3328
85. S.R. MacEwan, and A. Chilkoti Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake Nano Lett. 14 2014 2058 2064
86. N.Q. Shi, W. Gao, B. Xiang, and X.R. Qi Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage Int. J. Nanomedicine 7 2012 1613 1621
87. M. Whitney, E.N. Savariar, B. Friedman, R.A. Levin, J.L. Crisp, H.L. Glasgow, R. Lefkowitz, S.R. Adams, P. Steinbach, N. Nashi, Q.T. Nguyen, and R.Y. Tsien Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation Angew. Chem. Int. Ed. Eng. 52 2013 325 330
88. Z. Liu, M. Xiong, J. Gong, Y. Zhang, N. Bai, Y. Luo, L. Li, Y. Wei, Y. Liu, X. Tan, and R. Xiang Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment Nat. Commun. 5 2014 4280
89. Y. Yang, Y. Yang, X. Xie, Z. Wang, W. Gong, H. Zhang, Y. Li, F. Yu, Z. Li, and X. Mei Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery Biomaterials 48 2015 84 96
90. W. Lin, X. Xie, Y. Yang, H. Liu, X. Fu, Y. Chen, H. Liu, and Y. Yang Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands J. Pharm. Pharmacol. 67 2015 1215 1231
91. M. Tajes, E. Ramos-Fernandez, X. Weng-Jiang, M. Bosch-Morato, B. Guivernau, A. Eraso-Pichot, B. Salvador, X. Fernandez-Busquets, J. Roquer, and F.J. Munoz The blood-brain barrier: structure, function and therapeutic approaches to cross it Mol. Membr. Biol. 31 2014 152 167
92. K. Goyal, V. Koul, Y. Singh, and A. Anand Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances Cent. Nerv. Syst. Agents Med. Chem. 14 2014 43 59
93. S. Martel Learning from our failures in blood-brain permeability: what can be done for new drug discovery? Expert Opin. Drug Discov. 10 2015 207 211
94. R. Gabathuler Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol. Dis. 37 2010 48 57
95. H. Yang, H. Yang, Y. Lu, S. Ma, Y. Liu, G. Jia, J. Bi, and C. Wang Targeted delivery of extracellular matrix protected against neurologic defects after focal ischemia reperfusion in rats J. Stroke Cerebrovasc. Dis. 24 2015 154 162
96. N. Kamei, and M. Takeda-Morishita Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides J. Control. Release 197 2015 105 110
97. el-S. Khafagy, and M. Morishita Oral biodrug delivery using cell-penetrating peptide Adv. Drug Deliv. Rev. 64 2012 531 539
98. E.J. Nielsen, N. Kamei, and M. Takeda-Morishita Safety of the cell-penetrating peptide penetratin as an oral absorption enhancer Biol. Pharm. Bull. 38 2015 144 146
99. N. Kamei, Y. Onuki, K. Takayama, and M. Takeda-Morishita Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport J. Pharm. Sci. 102 2013 3998 4008
100. L. Di Strategic approaches to optimizing peptide ADME properties AAPS J. 17 2015 134 143
101. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 2008 1261 1268
102. Y.C. Kim, P.J. Ludovice, and M.R. Prausnitz Transdermal delivery enhanced by magainin pore-forming peptide J. Control. Release 122 2007 375 383
103. R. Sawant, and V. Torchilin Intracellular transduction using cell-penetrating peptides Mol. BioSyst. 6 2010 628 640
104. N. Do, G. Weindl, L. Grohmann, M. Salwiczek, B. Koksch, H.C. Korting, and M. Schafer-Korting Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin Exp. Dermatol. 23 2014 326 331
105. T. Hsu, and S. Mitragotri Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer Proc. Natl. Acad. Sci. U. S. A. 108 2011 15816 15821